David Elder, director of the
Office of Surveillance and Compliance in the FDA's Center for Veterinary Medicine, said during an earlier press conference that the agency relies more on testing and approving animal foods and drugs before they are put on
sale, rather than on
routine inspection due to «limited resources.»